Evidence map›Paper›PMID 35189179›Full record

ArticleNeurotoxicology2022

Butyrylcholinesterase in SH-SY5Y human neuroblastoma cells.

Seda Onder, Lawrence M Schopfer, Wei Jiang, Ozden Tacal, Oksana Lockridge

Open access · hybridAbstract read
In one paragraph

Article in Neurotoxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Seda OnderEppley Institute, University of Nebraska Medical Center, Omaha, NE 68198, USA; Department of Biochemistry, School of Pharmacy, Hacettepe University, Ankara 06100, Turkey. Electronic address: sedaonder@hacettepe.edu.tr.
Lawrence M SchopferEppley Institute, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: lmschopf@unmc.edu.
Wei JiangInstitute of Environmental Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China. Electronic address: jwei@zju.edu.cn.
Ozden TacalDepartment of Biochemistry, School of Pharmacy, Hacettepe University, Ankara 06100, Turkey. Electronic address: tacal@hacettepe.edu.tr.
Oksana LockridgeEppley Institute, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: olockrid@unmc.edu.
Hacettepe University · TRUniversity of Nebraska Medical Center · USZhejiang University · CN

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI James Eudy · 1985 to 2026
$55.0M
Crosslinking Action of Chlorpyrifos Oxon as Mechanism of Chronic IllnessR21ES030132 · NIEHS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LOCKRIDGE, OKSANA · 2020 to 2021
$419k
NCI NIH HHS P30 CA036727NIEHS NIH HHS R21 ES030132
6 · The paper itself

Abstract

Cultured SH-SY5Y human neuroblastoma cells are used in neurotoxicity assays. These cells express markers of the cholinergic and dopaminergic systems. Acetylcholinesterase (AChE) activity has been reported in these cells. Neurotoxic organophosphate compounds that inhibit AChE, also inhibit butyrylcholinesterase (BChE). We confirmed the presence of AChE in the cell lysate by activity assays, Western blot, and liquid chromatography-tandem mass spectrometry (LC-MS/MS) of immunopurified AChE. A nondenaturing gel stained for AChE activity identified the catalytically active AChE in SH-SY5Y cells as the unstable monomer. We also identified immature BChE in the cell lysate. The concentration of active BChE protein was similar to that of active AChE protein. The rate of substrate hydrolysis by AChE was 10-fold higher than substrate hydrolysis by BChE. The higher rate was due to the 10-fold higher specific activity of AChE over BChE (5000 units/mg for AChE; 500 units/mg for BChE). Neither cholinesterase was secreted. Tryptic peptides of immunopurified AChE and BChE were identified by LC-MS/MS on an Orbitrap Lumos Fusion mass spectrometer. The unfolded protein chaperone, binding immunoglobulin protein BiP/GRP78, was identified in the mass spectral data from all cholinesterase samples, suggesting that BiP was co-extracted with cholinesterase. This suggests that the cytoplasmic cholinesterases are immature forms of AChE and BChE that bind to BiP. It was concluded that SH-SY5Y cells express active AChE and active BChE, but the proteins do not mature to glycosylated tetramers.

Indexed as

NeuroblastomaNeurotoxicity SyndromesAcetylcholinesteraseButyrylcholinesteraseCholinesterase InhibitorsChromatography, LiquidHumansTandem Mass SpectrometryAcetylcholinesteraseButyrylcholinesteraseCholinesterase InhibitorsAcetylcholinesteraseBiP chaperoneButyrylcholinesteraseHuman neuroblastoma cellsMass spectrometryWestern blot

Identifiers

PMID35189179
PMCPMC9124689
OpenAlexW4213308020

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.